Perfil
Dr. Isabel Aznarez is a Chief Technology Officer at Stoke Therapeutics, Inc. She is on the Board of Directors at Oligonucleotide Therapeutics Society, Inc. She received her undergraduate degree from Universidad De La Republica Uruguay and a doctorate degree from the University of Toronto.
Cargos activos de Isabel Aznarez
| Empresas | Cargo | Inicio |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Fundador | 01/06/2014 |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Director/Miembro de la Junta | 01/01/2019 |
Formación de Isabel Aznarez.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Universidad De La Republica Uruguay
Universidad De La Republica Uruguay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Isabel Aznarez
















